How NeuroMetrix seeks to better relieve pain with AI
NeuroMetrix’s Quell 2.0 [Image courtesy of NeuroMetrix]NeuroMetrix plans to add artificial intelligence to the latest iteration of its Quell transcutaneous electrical nerve stimulation (TENS) device. AI will allow Quell 2.0 to tailor treatment to each individual user, according to the Waltham, Mass.–based based company. Launched in September 2018 Quell 2.0 is 50% smaller and 20% more powerful than the original Quell, which debuted in 2015. Quell is worn on the leg regardless of the site of pain and is designed to send neural pulses to the brain that trigger a natural pain relief response in the central nervous ...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Big Data Featured Health Information Technology mHealth (Mobile Health) News Well Pain Management Software / IT artificial intelligence Neurometrix opioid crisis Source Type: news
Medical News Today: What is a TENS unit and does it work?
Some people use a transcutaneous electrical nerve stimulation (TENS) unit to treat pain. This device works by sending electrical impulses through the skin. It may give people relief from the painful symptoms of arthritis, multiple sclerosis, fibromyalgia, endometriosis, and other conditions. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 9, 2018 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news
Will Investors Rescue Brazos & #039; Migraine Management Device?
A startup company trying to develop a new wearable migraine management therapy device is realizing that getting a new medical device to market can be a financial headache, pardon the pun. Southlake, TX-based Brazos Biomedical,Â an operating unit of American Diversified Holdings Corporation, said it needs about $2 million to complete all prototype development and FDA requirements to bring its Auracis wearable migraine device to market. Brazos hopes to work with institutional investors to devise a financing strategy to bring the device to market. TheÂ AuracisÂ is designed to be worn on the he...
Source: MDDI - August 2, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Brazos Medical needs $2m to get Auracis migraine device to market
American Diversified Holdings’ Brazos Biomedical needs $2 million to take its Auracis Tens migraine therapy system to the market, according to a recently released press release from the company. Houston-based Brazos said that its management met with medtech engineering firms and determined that a $2 million budget would float the device through from prototyping to production over a two year period. The Auracis device is designed to treat headache pain through the use of transcutaneous electrical nerve stimulation, and includes a number of electrodes designed to be placed at key points on the head and neck t...
Source: Mass Device - August 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management brazosbiomedical Source Type: news
Teardown: Inside the Neurometrix Quell TENS device
A TENS device for transcutaneous electrical nerve stimulation wraps around the upper calf much like a wristwatch wraps around the wrist. Here are some of its operational secrets. By Lee Teschler A medical device called a Quell performs what’s called transcutaneous electrical nerve stimulation on the lower leg. This technique is said to relieve diabetic pain. None of us here are diabetic so we can’t say whether the Quell actually does what its manufacturer — Neurometrix Inc. of Waltham, Mass. — claims it can do. What we can do is describe how the Quell is supposed to work and what we found...
Source: Mass Device - June 12, 2018 Category: Medical Devices Authors: MassDevice Tags: Neuromodulation/Neurostimulation Pain Management Neurometrix Source Type: news
American Diversified Holdings buys neuromod dev Brazos Biomedical
American Diversified Holdings said today it inked a deal to acquire Houston-based Brazos Biomedical for an undisclosed amount. Brazos Biomedical is developing the Auracis device, which is designed to treat headache pain through the use of transcutaneous electrical nerve stimulation. “Auracis has tremendous potential to alleviate suffering in people who suffer from migraine headaches. Our proprietary technology most closely mimics the most effective treatment for migraine at a fraction of the cost and without the risks of surgical implants,” David Foster of Brazos Biomedical said in a press release. The device i...
Source: Mass Device - April 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Neuromodulation/Neurostimulation brazosbiomedical Source Type: news
DJO Global to pay $8m to settle False Claims case
The U.S. Justice Dept. this week said that DJO Global agreed to pay more than $7.6 million to settle allegations that a former subsidiary submitted false claims to Tricare, the military’s health insurance arm. DJO, which wound down its Empi subsidiary in 2015, allegedly submitted claims to Tricare for “excessive, unnecessary” transcutaneous electrical nerve stimulation electrodes, the Justice Dept. said. The company used an “assumptive selling” technique to convince the insurer to buy “unjustifiably large quantities” of TENS electrodes from 2010 through 2015, “with ...
Source: Mass Device - January 25, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Neuromodulation/Neurostimulation DJO Global Source Type: news
Adhesive Considerations for Direct-Skin Wearable Medical Technologies
In addition to caring for the sick, today’s medical providers are also heavily focused on prevention, patient education, and health and wellness strategies. As part of this newer approach to healthcare, providers are implementing ways to deliver additional care options that are both easily accessible and more affordable. Of these, one of the fastest growing and most widely adopted is wearable medical technologies. Wearable medical technologies not only provide support for care related to acute and chronic medical conditions, but also for disease prevention and lifestyle choices. They can monitor health, remind patien...
Source: MDDI - January 23, 2018 Category: Medical Devices Authors: Janet Page Tags: MD & M West (Anaheim) Adhesives Source Type: news
Can Devices Replace Drugs for Migraine Treatment?
Migraine headache sufferers, particularly those who suffer from multiple debilitating episodes per month, can now ask their physicians about versatile non-pharmaceutical, non-invasive treatment devices that can both prevent migraines and lessen the severity of acute attacks. FDA has granted within the past few months expanded use clearance for two devices that work on the principle of neuromodulation. Interestingly enough, one of the devices, manufactured by Belgium-based Cefaly, had been cleared in 2014 for migraine prevention and was granted expanded approval for acute migraine treatment in November; the other, the Sprin...
Source: MDDI - December 29, 2017 Category: Medical Devices Authors: Greg Goth Tags: Electronics Source Type: news
5 Self-Care Trends According to Amazon Best-Seller and Wish Lists
To find out some of the latest trends in self care, we thought we’d check the world’s biggest marketplace, Amazon, for the best-selling and the most-wished-for medical supplies and equipment. Judging from the following rankings at Amazon, the biggest self-care trends are genetic testing, elimination assistance, fitness tracking, pain relief, and alcohol and marijuana use testing. On December 20, the top-10 best-selling medical supplies and equipment on Amazon were: 1. AncestryDNA Genetic Testing DNA Ancestry Kit 2. 23andMe DNA Test Ancestry Personal Genetic Service 3. Squatty Potty The Original Bathroom Toil...
Source: MDDI - December 20, 2017 Category: Medical Devices Authors: Daphne Allen Tags: Medical Device Business Source Type: news
7 medtech stories we missed this week: Nov. 17, 2017
[Image from unsplash.com]From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. The agreement comes after a strategic collaboration between the companies that allows Skyline to reach more markets. The joint venture leverages the Helomics D-Chip platform to develop and market new approaches for personalized cancer diagnostics and care. 2.&...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) mHealth (Mobile Health) Neurological Neuromodulation/Neurostimulation Regenerative Medicine Regulatory/Compliance Research & Development Helomics InnerScope iReliev LensAR Inc. Source Type: news
Is there a digital health solution for treating pain?
Could TENS devices be a potential answer to the opioid crisis? If they are, it’ll be thanks to digital health. Case in point is NeuroMetrix’s Quell device. Transcutaneous electrical nerve stimulation (TENS) gizmos have been around for decades. But they’ve had a reputation for being unwieldy, with a bunch of wires and pads. “TENS devices have been around for 40 years, and some of the reasons they’re not effective for chronic pain is that they are underpowered, not designed for 24/7 use, and they’re not dosing at the right levels for t...
Source: Mass Device - August 16, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Health Information Technology mHealth (Mobile Health) Pain Management devicetalksboston Neurometrix Source Type: news
Transcutaneous Electrical Nerve Stimulation
Title: Transcutaneous Electrical Nerve StimulationCategory: Procedures and TestsCreated: 2/3/2005 12:00:00 AMLast Editorial Review: 9/12/2016 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - September 12, 2016 Category: Anesthesiology Source Type: news
Bayer launches over-the-counter Aleve TENS pain device
Bayer (ETR:BAYN) said today it launched the Aleve direct therapy targeted transcutaneous electrical nerve stimulation pain relief device in the U.S. The device is designed as a non-invasive, drug-free method of pain control, specifically targeted at lower back pain, according to the company. “Aleve Direct Therapy puts controllable TENS technology in consumers hands without having to visit the doctor. It provides high intensity of power and its wireless remote control makes it easy to adjust the power of intensity to fit the user’s needs. We are pleased to be able to provide this safe, drug-free a...
Source: Mass Device - July 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Pain Management Bayer HealthCare Source Type: news
Bayer Announces the Launch of Aleve(R) Direct Therapy(TM) TENS Device to Help People who Suffer from Lower Back Pain
WHIPPANY, N.J., July 14, 2016 -- (Healthcare Sales & Marketing Network) -- Today, Bayer announced that Aleve® Direct Therapy, a safe, drug-free, pain relief device, is now available at retailers nationwide in the analgesics aisle. Aleve Direct Therap... Devices, Product LaunchBayer, Aleve Direct Therapy, Transcutaneous Electrical Nerve Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2016 Category: Pharmaceuticals Source Type: news
Dry mouth: Acupuncture-like electrical nerve stimulation may help
Phase III results indicate that acupuncture-like, transcutaneous electrical nerve stimulation may be equally effective as pilocarpine, the current prescription medication in a pill, to treat radiation-induced xerostomia (dry mouth), according to a new study published. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 29, 2015 Category: Science Source Type: news
RTOG 0537 shows acupuncture-like ENS may provide relief for radiation-induced dry mouth
(American Society for Radiation Oncology) Phase III results of Radiation Therapy Oncology Group 0537 indicate that acupuncture-like, transcutaneous electrical nerve stimulation may be equally effective as pilocarpine, the current prescription medication in a pill, to treat radiation-induced dry mouth, according to a study published in the June 1, 2015 issue of the International Journal of Radiation Oncology * Biology * Physics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2015 Category: Global & Universal Source Type: news
First device to prevent migraine headaches wins FDA approval
The US Food and Drug Administration has given its first approval for the marketing of a device for preventing migraine headaches. The federal agency says the device, which comes in the form of a headband that delivers a nerve-stimulating low electrical current, may bring relief to patients who cannot tolerate current migraine drugs."This is also the first transcutaneous electrical nerve stimulation device specifically authorized for use prior to the onset of pain," they told the press. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 12, 2014 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
FDA Approves Migraine Prevention Device (FREE)
By Kelly Young The FDA has approved marketing of the first device to prevent migraine headaches. The Cefaly transcutaneous electrical nerve stimulation (TENS) … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 12, 2014 Category: Primary Care Source Type: news
FDA Approves First Device to Prevent Migraine FDA Approves First Device to Prevent Migraine
The FDA allows marketing of a transcutaneous electrical nerve stimulation device for use prior to the onset of migraine pain. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2014 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news
FDA allows marketing of first medical device to prevent migraine headaches
Today, the U.S. Food and Drug Administration allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 11, 2014 Category: American Health Source Type: news
Transcutaneous Electrical Nerve Stimulation
Title: Transcutaneous Electrical Nerve StimulationCategory: Procedures and TestsCreated: 2/3/2005 10:20:00 PMLast Editorial Review: 10/30/2013 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - October 30, 2013 Category: Anesthesiology Source Type: news
Transcutaneous Nerve Stimulation Ineffective for Tennis ElbowTranscutaneous Nerve Stimulation Ineffective for Tennis Elbow
Transcutaneous electrical nerve stimulation (TENS) does not help tennis elbow, UK researchers say. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 10, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Parasacral TENS May Have Edge for Overactive Bladder in KidsParasacral TENS May Have Edge for Overactive Bladder in Kids
Parasacral transcutaneous electrical nerve stimulation (TENS) may have advantages over posterior tibial nerve stimulation (PTNS) in neuromodulatory treatment of children with overactive bladder. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 14, 2013 Category: Consumer Health News Tags: Urology News Source Type: news